Jazz Pharmaceuticals JAZZ Enterprise value

Enterprise value at other companies

AmgenAMGN

$252.17B+23.1%

AlkermesALKS

$9.79B+123%

Xenon PharmaceuticalsXENE

$5.72B+144%

Stoke Therapeutics, Inc.STOK

$1.77B+1,855%

Praxis Precision Medicines, Inc.PRAX

$8.86B+1,100%

Amneal Pharmaceuticals, Inc.AMRX

$7.97B+71.3%

FAQ

What is Jazz Pharmaceuticals's enterprise value?

Jazz Pharmaceuticals (JAZZ) reported enterprise value of $16.37B in Q1 2026.

How has Jazz Pharmaceuticals's enterprise value changed year-over-year?

Jazz Pharmaceuticals's enterprise value increased by 47.7% year-over-year, from $11.08B to $16.37B.

What is the long-term trend for Jazz Pharmaceuticals's enterprise value?

Over 5 years (2020 to 2025), Jazz Pharmaceuticals's enterprise value has grown at a 5.9% compound annual growth rate (CAGR), from $11.34B to $15.07B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.